High‐dose Tocopherol Acetate Therapy in Epidermolysis Bullosa Siblings of the Cockayne‐Touraine Type

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of dermatology (Print)

• Publication date

  1993-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1346-8138.1993.tb01372.xPMID 8300945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A perspective on the role of collagenase in recessive dystrophic epidermolysis bullosa.

  1988cited by this paper
• Vitamin E treatment of epidermolysis bullosa. Changes in tissue collagenase levels.

  1974cited by this paper
• TREATMENT OF EPIDERMOLYSIS BULLOSA

  1935cited by this paper

• Nutrition for Healthy Hair: Guide to Understanding and Proper Practice

  2020cites this paper
• The Hair Cycle and Its Relation to Nutrition

  2020cites this paper
• Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics.

  2017cites this paper
• Teaser Vitamin E is a lipid-soluble , radical buster existing in two different isoforms : tocotrienols and tocopherols

  2017cites this paper
• A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial

  2014cites this paper
• Наследственный буллезный эпидермолиз: современные представления об этиологии и патогенезе

  2013cites this paper
• Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial

  2012cites this paper
• Dosage and formulation issues: oral vitamin E therapy in children

  2009cites this paper
• The 2 nd Nordic symposium on Epidermolysis Bullosa 24 – 26 April , 2005

  2005cites this paper
• A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.

  2002cites this paper
• Epidermolysis Bullosa

  2002cites this paper
• Tetracycline and epidermolysis bullosa simplex: a new indication for one of the oldest and most widely used drugs in dermatology?

  1999cites this paper